The Problem Despite advances in digitizing supply chain management and making data-driven decisions, business planners and executives still expend significant time and effort on understanding ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...
At issue is the role pharmacy benefit mangers play in taking large discounts on drugs that advocates say are not passed along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback